Evaluation of Retinal Changes in Progressive Supranuclear Palsy and Parkinson Disease

被引:17
|
作者
Sevim, Duygu Gulmez [1 ]
Unlu, Metin [1 ]
Gultekin, Murat [2 ]
Karaca, Cagatay [1 ]
Mirza, Meral [2 ]
Mirza, Galip Ertugrul [1 ]
机构
[1] Erciyes Univ, Fac Med, Dept Ophthalmol, TR-38039 Kayseri, Turkey
[2] Erciyes Univ, Fac Med, Dept Neurol, Kayseri, Turkey
关键词
SEVERITY; ASSOCIATION; LEVODOPA;
D O I
10.1097/WNO.0000000000000591
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Differentiating Parkinson disease (PD) from progressive supranuclear palsy (PSP) can be challenging early in the clinical course. The aim of our study was to see if specific retinal changes could serve as a distinguishing feature. Methods: We used spectral domain optical coherence tomography (SD-OCT) with automatic segmentation to measure peripapillary nerve fiber layer thickness and the thickness and volume of retinal layers at the macula. Results: Thicknesses of superior peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell layer, inner plexiform layer, inner nuclear layer, and macular volume were more affected in PSP compared with PD (P < 0.05). Thicker inferotemporal pRNFL and lower macular volume were detected in levodopa users compared with nonusers in patients with PD. Conclusions: PD and PSP are associated with distinct changes in retinal morphology, which can be assessed with SD-OCT. (C) 2017 by North American Neuro-Ophthalmology Society
引用
收藏
页码:151 / 155
页数:5
相关论文
共 50 条
  • [41] Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease
    Lee, Young-Eun C.
    Williams, David R.
    Anderson, Jacqueline F. I.
    JOURNAL OF NEUROPSYCHOLOGY, 2016, 10 (01) : 1 - 14
  • [42] Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy
    Boelmans, Kai
    Holst, Brigitte
    Hackius, Marc
    Finsterbusch, Juergen
    Gerloff, Christian
    Fiehler, Jens
    Muenchau, Alexander
    MOVEMENT DISORDERS, 2012, 27 (03) : 421 - 427
  • [43] Validation of the Parkinson's Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy
    Klietz, Martin
    Eichel, Hannah V.
    Staege, Selma
    Kutschenko, Anna
    Respondek, Gesine
    Huber, Meret K.
    Greten, Stephan
    Hoeglinger, Gunter U.
    Wegner, Florian
    PARKINSONS DISEASE, 2021, 2021
  • [44] The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease
    Hardman, CD
    Halliday, GM
    EXPERIMENTAL NEUROLOGY, 1999, 158 (01) : 135 - 142
  • [45] Utilizing Speech Analysis to Differentiate Progressive Supranuclear Palsy from Parkinson Disease
    Kang, K.
    Nunes, A.
    Sharma, M.
    Hall, A.
    Mishra, R.
    Casado, J.
    Cole, R.
    Barchard, G.
    Vaziri, A.
    Wills, A.
    Pantelyat, A.
    MOVEMENT DISORDERS, 2023, 38 : S117 - S118
  • [46] Neuromelanin Imaging and Midbrain Volumetry in Progressive Supranuclear Palsy and Parkinson's Disease
    Taniguchi, D.
    Hatano, T.
    Kamagata, K.
    Okuzumi, A.
    Hori, M.
    Aoki, S.
    Hattori, N.
    MOVEMENT DISORDERS, 2018, 33 : S79 - S79
  • [47] PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease
    Ilgin, N
    Zubieta, J
    Reich, SG
    Dannals, RF
    Ravert, HT
    Frost, JJ
    NEUROLOGY, 1999, 52 (06) : 1221 - 1226
  • [48] The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy
    Hardman, CD
    Halliday, GM
    MOVEMENT DISORDERS, 1999, 14 (04) : 626 - 633
  • [49] Midbrain area for differentiating Parkinson's disease from progressive supranuclear palsy
    Ghourchian, Shadi
    Mousavi, Alireza
    Zamani, Babak
    Shahidi, Gholamali
    Rohani, Mohammad
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2019, 183
  • [50] Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy
    Ezquerra, Mario
    Pastor, Pau
    Gaig, Carles
    Vidal-Taboada, Jose M.
    Cruchaga, Carlos
    Munoz, Esteban
    Marti, Maria-Jose
    Valldeoriola, Francesc
    Aguilar, Miquel
    Calopa, Matilde
    Hernandez-Vara, Jorge
    Tolosa, Eduardo
    NEUROBIOLOGY OF AGING, 2011, 32 (03) : 547.e11 - 547.e16